TIME Names the 2024 TIME Person of the Year: Donald Trump
NEW YORK, Dec. 12, 2024 /PRNewswire/ — Today, TIME names Donald Trump, President-elect of the United States, as the 2024 TIME Person of the Year. time.com/poy#TIMEPOY See the cover, featuring a portrait of Donald Trump taken at Mar-a-Lago on Nov. 25 by Platon for TIME: https://bit.ly/4iLeaSr I
Neptune Software Transforms Enterprise Innovation with SAP-Native App Development Platform
Neptune DXP Offers a Uniquely Versatile and Future-Proof Solution for Enterprise App Development OSLO, Norway, Dec. 12, 2024 /PRNewswire/ — Leading low-code app development platform vendor Neptune Software‘s SAP-native app development platform is driving business process optimization ac
Jacobs Secures US Army Corps of Engineers Contract for Northwestern US, Alaska and Hawaii
Environmental and facilities design projects will support cleaner, more resilient communities DALLAS, Dec. 12, 2024 /PRNewswire/ — Jacobs (NYSE: J) was selected by the Omaha District of the U.S. Army Corps of Engineers (USACE) to deliver architecture and engineering services through a multiple
Xinhua Silk Road: Pien Tze Huang boosts TCM globalization
BEIJING, Dec. 12, 2024 /PRNewswire/ — Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd., a Fujian-based traditional Chinese medicine (TCM) company, has been striving to expand its overseas markets, enhancing the influence of TCM in regions such as Southeast Asia and Europe. Committed to deepen
Elevation Oncology Expands Pipeline with Nomination of EO-1022, a HER3 ADC for the Treatment of HER3-expressing Solid Tumors
— EO-1022 is comprised of seribantumab, an anti-HER3 monoclonal antibody, and an MMAE payload – — Following recently signed global license agreement with Synaffix, EO-1022 leverages the company’s GlycoConnect® and HydraSpace® ADC technologies for glycan site-specific conjugatio
Trevi Therapeutics Announces Positive Outcome from Sample Size Re-estimation Resulting in No Change to the Current Sample Size for the Phase 2b CORAL Trial in Idiopathic Pulmonary Fibrosis Patients with Chronic Cough
Independent Data Monitoring Statistician reaffirmed current sample size to remain at N=160 The trial has reached 75% of the targeted enrollment, and topline results continue to be expected in the first half of 2025 NEW HAVEN, Conn., Dec. 12, 2024 /PRNewswire/ — Trevi Therapeutics, Inc. (Nasda
Allegiant Reports November 2024 Traffic
LAS VEGAS, Dec. 12, 2024 /PRNewswire/ — Allegiant Travel Company (NASDAQ: ALGT) today reported preliminary passenger traffic results for November 2024. “Booking trends following the election continue to outpace our initial expectations,” stated Drew Wells, Chief Commercial Officer
Chronograph Launches Carta Capitalization Tables Integration
Mutual clients of Chronograph and Carta to benefit from automatic data exchange and display of Carta cap table data within the Chronograph for General Partners platform NEW YORK, Dec. 12, 2024 /PRNewswire/ — Chronograph, provider of next-generation portfolio monitoring technology for private
b.well Connected Health Names Sara Zywicki as Chief Product Officer
BALTIMORE, Dec. 12, 2024 /PRNewswire/ — b.well Connected Health, the leading platform for unified consumer health experiences, announced today that Sara Zywicki has joined the company as its Chief Product Officer. In this role, Zywicki will lead the strategy and execution of b.well’s pr
" title="Celebrating a Decade of Corby Safe Rides: From Toronto to Calgary, J.P. Wiser’s is Providing a “Wiser Way Home” This New Year’s Eve!
#CorbySafeRides Expands to the West. TORONTO and CALGARY, AB, Dec. 12, 2024 /CNW/ – As the leading manufacturer and distributor of spirits, wines, and ready-to-drink, Corby Spirit and Wine is celebrating its 10-year anniversary of providing Torontonians with an easy, complimentary and accessi
